Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06140992

PaCIFiC-CUP Classifies Cancer of Unknown Primary

PaCIFiC-CUP:Pan-Cancer Integrated Fingerprinting Classifier for Identifying the Origin of Cancer of Unknown Primary: A Multi-Center Prospective Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to initially utilize machine learning on pan-cancer DNA methylation data from public databases to construct a DNA methylation classification model (PaCIFiC-CUP, pan-cancer integrated fingerprinting classifier of CUP) for diagnosing various types of cancer, particularly the primary site of cancer of unknown primary. The goal is to achieve diagnosis of cancer pathology type by analyzing the DNA methylation patterns of cancer specimens, thereby guiding subsequent precision treatment for cancer.

Conditions

Timeline

Start date
2023-07-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2023-11-21
Last updated
2025-06-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06140992. Inclusion in this directory is not an endorsement.